The Full Climb: S$82,823 → S$150,000
Phase 1 — S$82,823 → S$100,000 (Target: 2026 H2–2027)
1) IBKR Cash Redeployment
USD112,942 idle cash deployed at ~5%, matching existing bond coupons. No new risk category introduced.
2) Schwab Reallocation
USD74,895 shifted toward dividend-focused holdings at ~4% yield.
3) New Capital / CPF ERS
Either ~S$124,000 fresh capital at 5%, or CPF ERS top-up (guaranteed, but locked until Jun 2029).
Phase 2 — S$100,000 → S$150,000 (Target: 2027–2032)
A) Bond Reinvestment on Roll
As Keppel REIT, StanChart, ESR-REIT and others reach call dates, reinvest at a modestly higher average coupon (~5.5% vs current ~4.6%) rather than accepting whatever the next coupon reset offers. Risk: reinvestment risk only — capital is not at risk beyond what it already was as a bondholder.
B) Modest Additional Leverage
Your current CIMB-linked financing sits at a conservative 25.6% loan-to-value against S$3.03M gross assets. Extending to a still-conservative 45% LTV (well below typical 50–60% ceilings) frees ~S$590,000 in financing capacity at an estimated 2% net spread (borrow ~3%, deploy ~5%). Risk: leverage amplifies both gains and losses; only pursue if rates stay favourable.
C) Dividend Equity Sleeve
Shifting ~40% of the USD255,001 IBKR equity position from growth-oriented holdings into dividend/REIT names yielding ~6% adds meaningful income with no new capital required. Risk: equity market risk, dividend cuts possible in downturns.
D) Diversified Private Credit
Deploying ~S$200,000 of new or freed-up capital into diversified structured credit or private debt (similar risk category to your existing Astrea 9 holdings) at ~7% yield. Risk: highest in this set — credit risk, illiquidity, and structural complexity. Diversify across multiple issuers; do not concentrate.
Timeline — Year by Year
| Period | Action | Income Added | Running Total | Risk Level |
|---|---|---|---|---|
| 2026 H2 | Redeploy IBKR USD cash + Schwab reallocation | +S$11,000 | S$93,823 | Low |
| 2027 | CPF/new capital decision resolved | +S$6,177 | S$100,000 | Low–Med |
| 2027–2028 | IBKR equity sleeve shifted to dividend/REIT yield | +S$5,853 | S$105,853 | Medium |
| 2028–2029 | Deploy into diversified private credit / structured notes | +S$14,000 | S$119,853 | Med–High |
| 2029 | Evaluate additional financing as first bond calls arrive (Keppel REIT) | monitor | S$119,853 | Review |
| 2029–2032 | Bond reinvestment at higher coupon on calls; phased leverage increase | +S$25,497 | S$145,350 | Medium |
Income Build by Lever
Risk Profile by Phase
What This Plan Deliberately Avoids
| Avoided | Why |
|---|---|
| Touching 401(k) / CPF principal | Retirement capital stays ring-fenced; only CPF ERS top-up (Phase 1, optional) is considered, and only as new contribution, never a withdrawal |
| Borrowing against the home | Additional leverage in Lever B uses existing insurance-linked facilities only, not property-secured debt |
| Concentrating in a single high-yield issuer | Lever D is explicitly diversified across multiple structured credit issuers, not a single concentrated bet |
| Chasing yield above ~7% | Yields meaningfully above 7% in current rate environment typically signal credit risk beyond what this plan accepts |
| Selling insurance policies for cash value | NTUC and Singlife cash values remain untouched — they continue compounding as designed |